This new study investigated a potential link found that apnea hypopnea index during the rapid eye movement (REM) sleep stage was associated with hypertension in patients with obstructive sleep apnea.

Use of a modified sleep apnea index can identify cardiovascular risk factors in adults with moderate to severe obstructive sleep apnea (OSA), according to results from a new study presented at the ...

A middle-age woman with high blood pressure and epilepsy gained 50 lb over the course of 2 years. What was the best approach to diagnosing her problem? The solution was to sleep on it, said Nancy ...

Sleep-related hypoxemia is a better indicator of atrial fibrillation (AF) risk than the commonly-used apnea-hypopnea index (AHI), new research suggests. "Our findings suggest the importance of looking ...

Findings show breathing sounds recorded by smartphones during sleep at home can reliably identify obstructive sleep apnea, presenting an innovative and accessible alternative to traditional ...

Please provide your email address to receive an email when new articles are posted on . Researchers found heightened odds for mortality among veterans with no sleep apnea vs. with mild to moderate ...

ORLANDO -- Tirzepatide (Zepbound) improved symptoms of moderate-to-severe obstructive sleep apnea (OSA) in people with obesity, regardless of positive airway pressure (PAP) use, the phase III SURMOUNT ...

Tirzepatide (Zepbound and Mounjaro), which is approved for chronic weight management and treatment of type 2 diabetes, has significant benefits for patients with moderate-to-severe obstructive sleep ...

CHICAGO -- A novel combination drug targeting neuromuscular dysfunction in obstructive sleep apnea (OSA) reduced severity of the condition in two pivotal randomized trials. In the SynAIRgy trial, ...

Apnimed has scored another phase 3 knockout. The Massachusetts biotech’s daily pill for obstructive sleep apnea (OSA) reduced the number of nightly breath-stopping events by 46.8%, smashing the ...